Condition

Cognitive Disorders

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting3
Common interventions23
Lead sponsors shown15
Advertisement

Clinical trials

17 shown
Breast Cancer and Chemobrain : Effects of Photobiomodulation on the Improvement of Perceived Cognitive ImpairmentNCT06995443 · 2025-06-13
RECRUITING
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked PotentialsNCT05888961 · 2023-06-12
RECRUITING
Cognitive Rehabilitation of Deficits in Patients With Multiple SclerosisNCT06964581 · 2023-02-08
RECRUITING
The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis PatientsNCT06697418 · 2024-10-01
ENROLLING_BY_INVITATION
Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related DisordersNCT03866018 · 2019-03-05
COMPLETED
Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis PatientsNCT02876536 · 2016-06-01
UNKNOWN
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome MeasuresNCT02777060 · 2014-09-01
UNKNOWN
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticENCT01772095 · 2013-02-01
COMPLETED
Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis PatientsNCT01659593 · 2012-09-01
UNKNOWN
Post-stroke Cognitive Impairment and DementiaNCT01339195 · 2010-08-01
COMPLETED
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan StudyNCT00937846 · 2009-07-15
COMPLETED
Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy SubjectsNCT00743405 · 2008-05-02
COMPLETED
Peer Support for Increasing Physical Activity in People With Serious Mental IllnessesNCT00458094 · 2007-03-01
COMPLETED
A Study of Decreased Mental Function Associated With HIVNCT00027040
COMPLETED
HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV DrugsNCT00001103
COMPLETED
A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With DementiaNCT00002154
COMPLETED
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV DementiaNCT00002148
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED10
RECRUITING3
UNKNOWN3
ENROLLING_BY_INVITATION1

Phase mix

NA10
PHASE13
PHASE21
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.